RD140
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RD140, covering 2024-10-23 to 2024-10-23. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]